A. Krishnan

发表

The role of vitamin D in reducing cancer risk and progression

E. Giovannucci, D. Feldman, B. Feldman, 2014, Nature Reviews Cancer.

Phase II study evaluating oral triamcinolone in patients with androgen-independent prostate cancer.

S. Srinivas, D. Feldman, A. Krishnan, 2006, Urology.

Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.

D. Peehl, N. Navone, D. Feldman, 1999, The Journal of urology.

Inhibition of prostaglandin synthesis and actions contributes to the beneficial effects of calcitriol in prostate cancer

S. Srinivas, D. Feldman, A. Krishnan, 2009, Dermato-endocrinology.

Calcitriol as a Chemopreventive and Therapeutic Agent in Prostate Cancer: Role of Anti‐Inflammatory Activity

D. Peehl, L. Nonn, D. Feldman, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Tumor Autonomous Effects of Vitamin D Deficiency Promote Breast Cancer Metastasis.

A. Aggarwal, B. Feldman, A. Krishnan, 2016, Endocrinology.

Years of Potential Life Lost Because of Cardiovascular Disease in Asian‐American Subgroups, 2003–2012

L. Palaniappan, F. Rodriguez, D. Boothroyd, 2019, Journal of the American Heart Association.

Calcitriol and genistein actions to inhibit the prostaglandin pathway: potential combination therapy to treat prostate cancer.

D. Peehl, D. Feldman, A. Krishnan, 2007, The Journal of nutrition.

Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer

D. Feldman, A. Krishnan, Jacqueline Moreno, 2005, The Journal of Steroid Biochemistry and Molecular Biology.

Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: Role of the direct inhibition of CYP24 enzyme activity

D. Peehl, D. Feldman, A. Krishnan, 2005, Molecular and Cellular Endocrinology.

Anti-inflammatory Activity of Calcitriol That Contributes to Its Therapeutic and Chemopreventive Effects in Prostate Cancer

D. Feldman, A. Krishnan, 2010 .

Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients

J. Brooks, C. Gardner, D. Peehl, 2009, International journal of cancer.

Tissue-Selective Regulation of Aromatase Expression by Calcitriol: Implications for Breast Cancer Therapy.

Jining Wang, D. Feldman, A. Krishnan, 2009, Endocrine reviews.

Potentiation of the growth-inhibitory effects of vitamin D in prostate cancer by genistein.

D. Peehl, D. Feldman, A. Krishnan, 2007, Nutrition reviews.

Pathways mediating the growth-inhibitory actions of vitamin D in prostate cancer.

D. Peehl, D. Feldman, A. Krishnan, 2003, The Journal of nutrition.

Nutritional Genomics in Cancer Processes Pathways Mediating the Growth-Inhibitory Actions of Vitamin D in Prostate Cancer 1

D. Peehl, D. Feldman, A. Krishnan, 2003 .

Stimulation of 1,25‐dihydroxyvitamin D3 receptor gene expression in cultured cells by serum and growth factors

D. Feldman, A. Krishnan, 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

1 a ,25-Dihydroxyvitamin D 3 Down-Regulates Estrogen Receptor Abundance and Suppresses Estrogen Actions in MCF-7 Human Breast Cancer Cells 1

D. Feldman, A. Krishnan, S. Swami, 2000 .

The Vitamin D Receptor Gene Start Codon Polymorphism: A Functional Analysis of FokI Variants

P. Malloy, D. Feldman, A. Krishnan, 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Inhibition of prostate cancer growth by vitamin D: Regulation of target gene expression

D. Peehl, D. Feldman, A. Krishnan, 2003, Journal of cellular biochemistry.

Vitamin D mitigates the adverse effects of obesity on breast cancer in mice.

A. Aggarwal, D. Feldman, R. Horst, 2016, Endocrine-related cancer.

1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.

D. Feldman, A. Krishnan, S. Swami, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Inhibitory Effects of Calcitriol on the Growth of MCF-7 Breast Cancer Xenografts in Nude Mice: Selective Modulation of Aromatase Expression in vivo

K. Jensen, D. Feldman, A. Krishnan, 2011, Hormones & cancer.

Estrogen down-regulation of androgen receptors in cultured human mammary cancer cells (MCF-7).

D. Feldman, A. Krishnan, E. Stover, 1987, Endocrinology.

Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D.

D. Feldman, A. Krishnan, 2011, Annual review of pharmacology and toxicology.

Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.

David Feldman, D. Peehl, L. Nonn, 2005, Cancer research.

CHAPTER 94 – Vitamin D and Prostate Cancer

A. Krishnan, 2005 .

A glucocorticoid-responsive mutant androgen receptor exhibits unique ligand specificity: therapeutic implications for androgen-independent prostate cancer.

K. R. Ely, D. Peehl, D. Feldman, 2002, Endocrinology.

Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

Donna M. Peehl, David Feldman, D. Peehl, 2000, Nature Medicine.

Analysis of vitamin D‐regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays

J. Brooks, N. Raghavachari, R. Shinghal, 2004, The Prostate.

Vitamin D and breast cancer: Inhibition of estrogen synthesis and signaling

D. Feldman, A. Krishnan, S. Swami, 2010, The Journal of Steroid Biochemistry and Molecular Biology.

CHAPTER 13 – Vitamin D: Biology, Action, and Clinical Implications

E. Balint, P. Malloy, D. Feldman, 2008 .

Equivalent anticancer activities of dietary vitamin D and calcitriol in an animal model of breast cancer: Importance of mammary CYP27B1 for treatment and prevention

D. Feldman, A. Krishnan, S. Swami, 2013, The Journal of Steroid Biochemistry and Molecular Biology.

Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells

D. Feldman, A. Krishnan, S. Swami, 2006, Molecular Cancer Therapeutics.

Anti-inflammatory Activity of Calcitriol in Cancer

D. Feldman, A. Krishnan, 2011 .

Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.

D. Feldman, A. Krishnan, 2010, Endocrine-related cancer.

Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancer

D. Feldman, A. Krishnan, S. Swami, 2012, The Prostate.

EnhancedAnticancerActivity and Increased HypercalcemicToxicity in aMouseXenograft Modelof ProstateCancer

D. Feldman, A. Krishnan, S. Swami, 2012 .

The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer

D. Feldman, A. Krishnan, S. Swami, 2012, Steroids.

Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D

M. Diehn, D. Feldman, R. Horst, 2015, Molecular Cancer Therapeutics.

The role of vitamin D in cancer prevention and treatment.

D. Trump, Candace S. Johnson, D. Feldman, 2012, Rheumatic diseases clinics of North America.

Vitamin D metabolism and action in the prostate: Implications for health and disease

D. Feldman, A. Krishnan, S. Swami, 2011, Molecular and Cellular Endocrinology.

Vitamin D inhibition of the prostaglandin pathway as therapy for prostate cancer.

S. Srinivas, D. Peehl, D. Feldman, 2007, Nutrition reviews.

The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃.

R. Bouillon, G. Eelen, D. Feldman, 2011, Best practice & research. Clinical endocrinology & metabolism.

The role of vitamin D in cancer prevention and treatment.

D. Trump, Candace S. Johnson, D. Feldman, 2012, Rheumatic diseases clinics of North America.

Atherosclerotic Cardiovascular Disease in South Asians in the United States: Epidemiology, Risk Factors, and Treatments: A Scientific Statement From the American Heart Association.

K. Watson, L. Palaniappan, J. Lichtman, 2018, Circulation.

Inflammatory bowel disease and environmental influences.

J. Korzenik, A. Krishnan, 2002, Gastroenterology clinics of North America.

Estradiol inhibits glucocorticoid receptor expression and induces glucocorticoid resistance in MCF-7 human breast cancer cells

D. Feldman, A. Krishnan, S. Swami, 2001, The Journal of Steroid Biochemistry and Molecular Biology.

Erratum: Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor (Nature Medicine (2000) 6 (703-706))

D. Peehl, N. Navone, P. Malloy, 2000 .

Vitamin D: Biology, Actions, and Clinical Implications

D. Feldman, A. Krishnan, S. Swami, 2001 .

Vitamin D and prostate cancer.

D. Peehl, D. Feldman, A. Krishnan, 1995, Advances in experimental medicine and biology.

1α,25-Dihydroxyvitamin D3 Down-Regulates Estrogen Receptor Abundance and Suppresses Estrogen Actions in MCF-7 Human Breast Cancer Cells

D. Feldman, A. Krishnan, S. Swami, 2000 .

Editorial/Mini-Review: Vitamin D and Prostate Cancer.

D. Feldman, A. Krishnan, Xiao-yan Zhao, 2000, Endocrinology.

Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis

J. Brooks, R. Shinghal, D. Peehl, 2004, The Journal of Steroid Biochemistry and Molecular Biology.

Novel pathways that contribute to the anti-proliferative and chemopreventive activities of calcitriol in prostate cancer

D. Peehl, L. Nonn, P. Malloy, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements.

D. Feldman, A. Krishnan, S. Swami, 2013, Endocrine-related cancer.

Mechanisms of vitamin D-mediated growth inhibition in prostate cancer cells: inhibition of the prostaglandin pathway.

D. Peehl, D. Feldman, A. Krishnan, 2006, Anticancer research.

Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.

K. Jensen, D. Feldman, R. Horst, 2012, Endocrinology.

Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy.

Jining Wang, D. Feldman, A. Krishnan, 2009, Endocrinology.

The role of vitamin D in cancer prevention and treatment.

D. Trump, Candace S. Johnson, D. Feldman, 2010, Endocrinology and metabolism clinics of North America.

Activation of protein kinase-C inhibits vitamin D receptor gene expression.

D. Feldman, A. Krishnan, A. Krishnan, 1991, Molecular endocrinology.

Regulation of 1,25-dihydroxyvitamin D3 receptors by parathyroid hormone in osteoblastic cells: role of second messenger pathways.

S. Cramer, D. Feldman, A. Krishnan, 1995, Endocrinology.

Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving.

D. Feldman, A. Krishnan, L. Tőkés, 1993, Endocrinology.

Vitamin D metabolism and action in the prostate: Implications for health and disease

D. Feldman, A. Krishnan, S. Swami, 2011, Molecular and Cellular Endocrinology.

Candida albicans estrogen-binding protein gene encodes an oxidoreductase that is inhibited by estradiol.

P. Malloy, D. Feldman, A. Krishnan, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Estrogens in unexpected places: possible implications for researchers and consumers.

D. Feldman, A. Krishnan, A. Krishnan, 1995, Environmental health perspectives.

Vitamin D mitigates the adverse effects of obesity on breast cancer in mice.

D. Feldman, R. Horst, B. Feldman, 2016, Endocrine-related cancer.

The role of vitamin D in prostate cancer.

D. Peehl, D. Feldman, A. Krishnan, 2001, Steroids.